S Frustaci

Summary

Affiliation: Centro di Riferimento Oncologico
Country: Italy

Publications

  1. ncbi request reprint Ifosfamide in the adjuvant therapy of soft tissue sarcomas
    S Frustaci
    Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, General Hospital, Gorizia, Italy
    Oncology 65:80-4. 2003
  2. doi request reprint Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
    Sergio Frustaci
    Division of Medical Oncology B, National Cancer Institute CRO, Via Franco Gallini, 2, 33081, Aviano, PN, Italy
    Int J Clin Oncol 18:510-6. 2013
  3. ncbi request reprint Adjuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group
    Sergio Frustaci
    Department of Medical Oncology, National Cancer Institute, Aviano
    Tumori 92:92-7. 2006
  4. ncbi request reprint Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study
    S Frustaci
    Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy
    J Clin Oncol 15:1418-26. 1997
  5. ncbi request reprint Metastatic angiosarcoma of the spleen. A case report and treatment approach
    M Rupolo
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori, Aviano, Italy
    Tumori 87:439-43. 2001
  6. ncbi request reprint Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors
    S Frustaci
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    Tumori 85:229-33. 1999
  7. ncbi request reprint Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature
    M Berretta
    Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    J Chemother 18:221-4. 2006
  8. ncbi request reprint FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Chemother 20:503-8. 2008
  9. ncbi request reprint Prognostic factors in soft tissue sarcomas: a study of 395 patients
    P D Stefanovski
    Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy
    Eur J Surg Oncol 28:153-64. 2002
  10. ncbi request reprint Cisplatin and mitomycin C in advanced chemotherapy-refractory breast cancer
    D Crivellari
    Medical Oncology Department, Centro di Riferimento Oncologico, Aviano, Pordenone, Italy
    Tumori 76:234-7. 1990

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Ifosfamide in the adjuvant therapy of soft tissue sarcomas
    S Frustaci
    Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, General Hospital, Gorizia, Italy
    Oncology 65:80-4. 2003
    ..However, the 5-year overall survival estimate, which is a reasonable end point for the survival analysis of adjuvant treatment in soft tissue sarcomas, was 66.0 and 46.1% for the treatment and the control groups, respectively (p = 0.04)...
  2. doi request reprint Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
    Sergio Frustaci
    Division of Medical Oncology B, National Cancer Institute CRO, Via Franco Gallini, 2, 33081, Aviano, PN, Italy
    Int J Clin Oncol 18:510-6. 2013
    ..A combination of docetaxel (D), oxaliplatin (O), and capecitabine (C) (DOC) was studied in this dose-escalation phase Ib trial in patients with untreated advanced gastric cancer...
  3. ncbi request reprint Adjuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group
    Sergio Frustaci
    Department of Medical Oncology, National Cancer Institute, Aviano
    Tumori 92:92-7. 2006
    ..The aim of this study was to test the protocol reproducibility when applied as a standard practice...
  4. ncbi request reprint Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study
    S Frustaci
    Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy
    J Clin Oncol 15:1418-26. 1997
    ....
  5. ncbi request reprint Metastatic angiosarcoma of the spleen. A case report and treatment approach
    M Rupolo
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori, Aviano, Italy
    Tumori 87:439-43. 2001
    ....
  6. ncbi request reprint Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors
    S Frustaci
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    Tumori 85:229-33. 1999
    ..To evaluate the maximum tolerated doses (MTD) of ifosfamide when given as a continuous infusion and in combination with fixed doses of bolus 4'-epidoxorubicin in advanced previously untreated adult soft tissue sarcoma patients...
  7. ncbi request reprint Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature
    M Berretta
    Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    J Chemother 18:221-4. 2006
    ..Antiangiogenetic agents are of interest for this disease due to the peculiar origin of the cells of these sarcomas...
  8. ncbi request reprint FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Chemother 20:503-8. 2008
    ..9 and 21.8 months, respectively) between middle aged and elderly patients. The FOLFOX2 regimen provides equivalent feasibility, efficacy, and survival gain in middle-aged and in elderly patients with metastatic CRC...
  9. ncbi request reprint Prognostic factors in soft tissue sarcomas: a study of 395 patients
    P D Stefanovski
    Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy
    Eur J Surg Oncol 28:153-64. 2002
    ..The aim of this study was to report prognostic factors, end-points of local recurrence, distant recurrence, post-metastasis survival, and overall survival in a cohort of patients with soft tissue sarcomas...
  10. ncbi request reprint Cisplatin and mitomycin C in advanced chemotherapy-refractory breast cancer
    D Crivellari
    Medical Oncology Department, Centro di Riferimento Oncologico, Aviano, Pordenone, Italy
    Tumori 76:234-7. 1990
    ..We conclude that at these doses and schedule, the cisplatin and mitomycin C combination has a limited efficacy in advanced breast cancer patients, and its use is not recommended in pretreated patients...
  11. ncbi request reprint Efficacy of total androgen blockade in metastatic prostatic carcinoma with transient hypogonadotropic hypogonadism: a case report
    G Lo Re
    Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy
    Tumori 85:280-3. 1999
    ..The interest of this case lies in the incidental detection of HH during therapy and in the responsiveness to treatment...
  12. ncbi request reprint Retrospective analysis of the CYVADIC regimen in advanced soft tissue sarcomas
    S Frustaci
    Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Pordenone, Italy
    Tumori 75:152-5. 1989
    ....
  13. ncbi request reprint Intraoperative radiation therapy for retroperitoneal soft tissue sarcomas
    A De Paoli
    Radiation Oncology, Surgical Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy
    J Exp Clin Cancer Res 22:157-61. 2003
    ..The new phase II trial, activated within the Italian Sarcoma Group, with preoperative concurrent chemo-radiation therapy and IORT is presented...
  14. ncbi request reprint Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy
    M Berretta
    Division of Medical Oncology A and 3B National Cancer Institute, Aviano, Italy
    J Chemother 16:595-8. 2004
    ..This toxic effect was self-limiting and all patients recovered rapidly. Nonetheless, a deeper understanding of this phenomenon is essential to give correct information to the patients...
  15. ncbi request reprint Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
    A De Paoli
    Department of Radiation Oncology, C R O National Cancer Institute, Aviano, Italy
    Ann Oncol 17:246-51. 2006
    ..The aim of the study was to evaluate tolerance and efficacy of preoperative treatment with capecitabine in combination with radiation therapy (RT) in patients with locally advanced, resectable, rectal cancer...
  16. ncbi request reprint Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case report
    A Bearz
    Department of Medial Oncology B, CRO IRCSS, National Cancer Institute, Aviano, Italy
    Tumori 87:447-50. 2001
    ..The course of the small cell lung cancer was very indolent and the paraneoplastic neurologic syndrome did not worsen with the use of cisplatin...
  17. ncbi request reprint The evolution of integrated treatment of soft tissue sarcoma at the Rizzoli Orthopaedic Institute
    F Gherlinzoni
    Primario UO Ortopedia, Ospedale Civile, Gorizia
    Chir Organi Mov 89:95-105. 2004
    ..Conclusions based on our vast previous experience lead us to believe that adjuvant chemotherapy must be used for all patients with high-risk soft tissue sarcoma within clinical trials...
  18. ncbi request reprint Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial
    S Frustaci
    , Centro di Riferimento Oncologico, Aviano, Italy. sfrustaci.cro.it
    J Clin Oncol 19:1238-47. 2001
    ..Although cure is still difficult to achieve, a significant delay in death is worthwhile, also considering the short duration of treatment and the absence of toxic deaths...
  19. ncbi request reprint FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients
    M Berretta
    Ann Oncol 17:1606-7. 2006
  20. ncbi request reprint Ovarian cancer: ten-year experience in a community hospital
    G Franchin
    Division of Radiotherapy, Centro di Riferimento Oncologico, Aviano Pordenone, Italy
    Tumori 73:381-8. 1987
    ..Patients with advanced disease, considering the lack of established efficacious treatments, should be referred to specialized centers, where new drugs or experimental strategies can be tested...